Angioedema: A potential complication of dupilumab in atopic dermatitis

Angioedema: A potential complication of dupilumab in atopic dermatitis

Dupilumab is a relatively new and quite effective medication for recalcitrant atopic dermatitis in patients over 6 years of age. Here, we present a 12‐year‐old girl with progressively worsening episodic facial swelling and erythema while treated with dupilumab. This case highlights the possibility o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric dermatology 2021-01, Vol.38 (1), p.237-238
Hauptverfasser: Fritz, Andrea L., Lacy, Frank A., Morrell, Dean S.
Format: Artikel
Sprache:eng
Schlagworte:
Angioedema
Angioedema - chemically induced
Angioedema - drug therapy
Antibodies, Monoclonal, Humanized - adverse effects
Atopic dermatitis
biologic
Case reports
Child
Dermatitis
Dermatitis, Atopic - drug therapy
drug reaction
dupilumab
Eczema
Edema
Erythema
Female
Humans
Immunotherapy
Monoclonal antibodies
Pediatrics
Side effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dupilumab is a relatively new and quite effective medication for recalcitrant atopic dermatitis in patients over 6 years of age. Here, we present a 12‐year‐old girl with progressively worsening episodic facial swelling and erythema while treated with dupilumab. This case highlights the possibility of angioedema as an adverse effect of dupilumab treatment.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.14434